Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Gastroenterology. 2010 Mar 27;139(1):93–101. doi: 10.1053/j.gastro.2010.03.055

Table 4.

Association between ≥2 years supply of proton pump inhibitors and the risk of hip fracture, stratified by time since most recent prescription.

User Status Interval Since Last Prescription1 Cases Controls Adjusted Odds Ratios 95% Confidence Intervals2
No Use 84,913 20,498 Reference
≥2 years supply All Users All Persons with ≥2 years supply 1558 4806 1.30 (1.21 – 1.39)
Current vs. Former Users3 Current User Prescription in last year 1288 3958 1.30 (1.21 – 1.41)
Recent User Last Prescription 1–1.9 years prior 73 220 1.24 (0.90 – 1.72)
Former User Last Prescription 2–2.9 years prior 23 84 1.09 (0.64 – 1.85)
Former User Last Prescription 3–5.9 years prior 15 87 0.69 (0.37 – 1.28)
1

Time between index date and last PPI prescription among persons with ≥2 years supply of proton pump inhibitors prior to their index date. A current user, for example, would have received at least one prescription in the year prior to hip fracture (or the comparable index date for controls)

2

Cases and controls were individually matched for sex, age, duration of membership, first year of membership, and race/ethnicity; models were adjusted for a smoking diagnosis.

3

Among subjects with ≥2 years supply